ICH Q9 Training Course

ICH Q9 Training Course

Berlin, Germany

Seminar Nr. 15513


Dieses Seminar/Webinar kann nicht gebucht werden. Alternative Termine für dieses Seminar/Webinar und ähnliche Veranstaltungen finden Sie in der Übersicht nach Thema..

Für viele Seminare und Webinare gibt es auch Aufzeichnungen, die Sie jederzeit bestellen und anschauen können. Diese Aufzeichnungen finden Sie in einer themensortierten Liste.

Oder senden Sie uns Ihre Anfrage einfach über das folgende Kontaktformular.

* auch unkompliziert per Kreditkarte bezahlbar American Express Visa Mastercard

Rückfragen unter:
Tel.: 06221 / 84 44 0 E-Mail: info@concept-heidelberg.de


Richard M. Bonner, formerly with Eli Lilly, United Kingdom

Dr Helene Zuurmond, Pfizer, Belgium

Dr Heinrich Prinz, Apceth GmbH, Germany

Dr Thomas Schneppe, Bayer Pharma AG, Berlin, Germany


The Guideline ICH Q9 „Quality Risk Management“ was finalised in November 2005 (Step 5). Consequently, this guideline has been implemented in the EU, the US (FDA) and in Japan.

The ICH Q9 training course in hand deals with the practical implementation of the requirements. Individual examples help to show the application in the following GMP areas:
Change Control/Change Management
Quality Systems

As a complement to the lectures, the closing workshop offers the opportunity to practise Quality Risk Management techniques with a case study.


This event has been designed for quality assurance personnel. It also addresses staff from other departments, like e.g. production, engineering, quality control, and regulatory affairs.


ICH Q 9 Quality Risk Management

  • Basic requirements
  • Comparison to ISO 14971
  • Practical Examples
How to Realise Quality Risk Management in a GMP Environment
  • An overview of the diverse techniques (HACCP, FTA etc.)
  • Access benefit of some tools
  • Examples from the production of drug (medicinal) products and APIs
How to Apply Quality Risk Management in Validation
  • Understand why the use of risk management in process validation is now expected
  • What does the FDA expect for batch conformance prior to and post product approval
  • What is the benefit of using the risk management approach versus the traditional 3 batch validation approach?
  • What does ICH Q9 mean with respect to quality risk management in validation
  • Learn why the quality risk management approach to validation will result in less ongoing process support during production
Design of an Event Handling System based on a Quality System and Quality Risk Management Approach
  • The quality system
  • Risk management principles
  • Events (e. g. deviations, complaints etc.)
  • Risk management application
  • Outputs
How to implement Quality Risk Management in a Pharmaceutical Company
  • The risk-based approach and its impact on key GMP processes (GAMP®5,
  • FDA Guidance on Process Validation, etc)
  • ICH Q9 in the context of ICH Q8 and ICH Q10
  • The implementation of „quality risk management thinking and doing“ on
  • management and shop floor level (tools and experiences)
How to Make a Risk-based Audit Schedule
  • Understand how to assess risk between different operations
  • Identify priorities for the audit
  • Learn how to use a point system to assign audit priorities based on risk
  • How to use a template to make a risk-based audit schedule
Workshop Quality Risk Management in Practice
Learn how to create an audit schedule by looking at the various risk categories associated with the various operational activities within the differing units. This workshop will help you look across the different units from production operations, vendors, third-parties and laboratories, rank them by risk and then apply this to a template to create an audit schedule covering the next 3 years.

After the workshop you will be able to use or adapt the template to conduct a similar risk profile for your own facilities and third-party operations


GMP Seminare nach Thema